Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irbesartan antagonism of angiotensin II receptors in sepsis
2012-001100-38Phase 3Terminated
- Sponsor
- Department of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples Federico II
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of irbesartan in sepsis, sponsored by Department of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples Federico II. Primary endpoint: Mortality rate and incidence of multiple organ failure. Started Apr 2014; status: terminated.
02
Drugs
irbesartan
03
Conditions
sepsis
Beyond the preview
Go deeper on 2012-001100-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001100-38.